Frontlight ResearchEarly access
Active, not recruitingNo phase
miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction
Key facts
- Who runs it
- Chiang Mai University
- Where
- Thailand1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 160 people enrolled
- Started
- 26 Aug 2000
- Ended
- 17 Mar 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- blood draw
- Record updated
- 18 March 2026
Who can take part
- Age
- Up to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- singleton pregnant women who attend at our clinic in first trimester
Who cannot take part
- known underlying disease such as chronic hypertension, pregestational diabetes, SLE
- normal structural fetal anatomical screening
- incomplete obstetric data
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups.
Read full original descriptionShow less
Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.
The 2 groups in the trial
- Pregnancy with GDM
Pregnant women who positive test for 100gm OGTT (abnormal 2 or more blood glucose level according NDDG (National Diabetes Data Group) criteria)
Treatment: blood draw
- Pregnancy without GDM
Pregnant women who negative test for 100gm OGTT
Treatment: blood draw
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- miRNA and FGF21 Profile in First Trimester and Efficacy of Gestational Diabetes Prediction and Pregnancy Outcomes
- Record updated
- 18 March 2026